These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12741452)

  • 21. Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.
    Kar P; Chandrashekar N; Devi S; Bhatia SJ; Alvares JF; Taneja A; Towar A
    Indian J Gastroenterol; 2003; 22(4):153. PubMed ID: 12962446
    [No Abstract]   [Full Text] [Related]  

  • 22. [The impact of rabeprazole treatment on the quality of life in patients with reflux esophagitis and non-erosive reflux disease].
    Liu XH; Ke MY; Song ZQ; Luo JY; Yuan YZ; Hou XH; Zhu YL; Sun J; Zha H
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):818-21. PubMed ID: 16316559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of non-erosive minimal esophageal lesions in gastro-esophageal reflux disorder.
    Hong SP; Park PW; Hwang SG; Ko KH; Kwak SY; Kim SH; Kwon KS; Shin YW; Ryu JK; Ryu KH; Park SJ; Won WH; Yoo HM; Bae HM; Park MJ; Woo YK; Kim KC; Kim KH; Na SH; Kim JW
    Korean J Intern Med; 2004 Jun; 19(2):93-8. PubMed ID: 15366639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of the Gastroesophageal Reflux Disease Treatment Satisfaction Questionnaire.
    Shikiar R; Flood E; Siddique R; Howell J; Dodd SL
    Dig Dis Sci; 2005 Nov; 50(11):2025-33. PubMed ID: 16240210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
    Bytzer P; Blum A; De Herdt D; Dubois D;
    Aliment Pharmacol Ther; 2004 Jul; 20(2):181-8. PubMed ID: 15233698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.
    Fock KM; Teo EK; Ang TL; Chua TS; Ng TM; Tan YL
    World J Gastroenterol; 2005 May; 11(20):3091-8. PubMed ID: 15918196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failures in a proton pump inhibitor therapeutic substitution program: lessons learned.
    Lu M; Malladi V; Agha A; Abudayyeh S; Han C; Siepman N; Graham DY
    Dig Dis Sci; 2007 Oct; 52(10):2813-20. PubMed ID: 17393309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor.
    Oda K; Iwakiri R; Hara M; Watanabe K; Danjo A; Shimoda R; Kikkawa A; Ootani A; Sakata H; Tsunada S; Fujimoto K
    Dig Dis Sci; 2005 Oct; 50(10):1921-6. PubMed ID: 16187198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Financial restrictions in health care systems could affect treatment quality of GERD-patients].
    Gillessen A; Schöffel L; Naumburger A
    Z Gastroenterol; 2006 May; 44(5):379-85. PubMed ID: 16688654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.
    Calleja JL; Suarez M; De Tejada AH; Navarro A;
    Dig Dis Sci; 2005 Mar; 50(3):432-9. PubMed ID: 15810621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients.
    Kusano M; Shimoyama Y; Kawamura O; Maeda M; Kuribayashi S; Nagoshi A; Zai H; Moki F; Horikoshi T; Toki M; Sugimoto S; Mori M
    Dig Dis Sci; 2007 Jul; 52(7):1673-7. PubMed ID: 17385034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole.
    Johnson M; Guilford S; Libretto SE;
    Curr Med Res Opin; 2002; 18(5):303-10. PubMed ID: 12240793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: case report.
    Alfonzo CA; Bobo WV; Almond MD
    Int J Psychiatry Med; 2003; 33(3):311-5. PubMed ID: 15089012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabeprazole.
    Pace F; Coudsy B; DeLemos B; Sun Y; Xiang J; LoCoco J; Casalini S; Li H; Pelosini I; Scarpignato C
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):845-51. PubMed ID: 21900784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.
    Birbara C; Breiter J; Perdomo C; Hahne W
    Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):889-97. PubMed ID: 10958216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease.
    Lee YC; Lin JT; Wang HP; Chiu HM; Wu MS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1286-92. PubMed ID: 17559380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg.
    Morgan DG; O'Mahony MF; O'Mahony WF; Roy J; Camacho F; Dinniwell J; Horbay GL; Husein-Bhabha FA;
    Can J Gastroenterol; 2007 Dec; 21(12):820-6. PubMed ID: 18080054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.